BASF vs TATVA: Stock Comparison

BASF India Limited vs Tatva Chintan Pharma Chem Limited

Live data: 27 July 2026, 9:41 AM IST • Source: NSE and company filings

BASF India Limited is the larger company by market capitalisation. BASF India Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Tatva Chintan Pharma Chem Limited shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of BASF India Limited and Tatva Chintan Pharma Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BASF is more favourable on 7 of 13 scored metrics and TATVA on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
BASF is the larger company
₹15,955 Cr vs ₹4,070 Cr
P/E Ratio
BASF has a lower P/E
37.82x vs 78.3x
P/B Ratio
BASF has a lower P/B
4.01x vs 5.15x
EPS
BASF has higher earnings per share
₹96.16 vs ₹18.84
Dividend Yield
BASF has a higher dividend yield
0.68% vs 0.08%
Revenue Growth (TTM YoY)
TATVA has faster revenue growth
24.4% vs 4.8%
EPS Growth (TTM YoY)
TATVA has faster EPS growth
907.5% vs 155%
Qtr Sales Growth
TATVA has stronger quarterly sales growth
24.4% vs 4.78%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBASFTATVA
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricBASFTATVA
Live Price₹3,732.5₹1,755.7
Day Change1.7%1.93%
Volume1,09455,323
52-Week High₹5,150₹1,785
52-Week Low₹3,122.2₹976.4
Distance from 52W High-27.52%-1.64%

Valuation

MetricBASFTATVA
Market Cap₹15,955 Cr₹4,070 Cr
P/E Ratio37.82x78.3x
P/B Ratio4.01x5.15x
EPS₹96.16₹18.84
Book Value₹914.27₹334.03
Dividend Yield0.68%0.08%

Growth

MetricBASFTATVA
Revenue Growth (TTM YoY)4.8%24.4%
EPS Growth (TTM YoY)155%907.5%
Qtr Sales Growth4.78%24.4%
Qtr Profit Growth202%902%

Profitability & Leverage

MetricBASFTATVA
ROE11%5.53%
ROCE14.7%7.14%
Net Margin2.76%8.31%
Operating Margin4.41%11.13%
Debt to Equity0.03x15.4x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBASFTATVA
Promoter Holding0%72.02%
FII Holding5.21% 0.13 pp3.93% 0.11 pp
DII Holding6.29%3.11% 0.12 pp
Public Holding15.17% 0.13 pp20.94% 0.23 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BASF India Limited and Tatva Chintan Pharma Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.